Group topline
(in millions of euro)
| 3Q21
| 2Q21
| 1Q21
| 4Q20
| 3Q20
| Change 3Q21 vs 3Q20
|
Orders
| 225.1
| 236.6
| 228.9
| 189.7
| 157.6
| +43%
|
Sales
| 186.7
| 194.3
| 171.7
| 195.4
| 167.4
| +12%
|
Third quarter orders reflect continued demand recovery in all of Barco’s markets and across all regions fueled by significant year-over-year growth for both Cinema and ClickShare.
Although sales were up year-over-year in all divisions, component shortages continued to cause delays in converting orders to sales (impact 15 million euro).
Sales growth was particularly strong in the Americas. Sales in the APAC region were weak reflecting a slower pace of recovery from the pandemic.
Divisional breakdown
Entertainment
(in millions of euro)
| 3Q21
| 2Q21
| 1Q21
| 4Q20
| 3Q20
| Change 3Q21 vs 3Q20
|
Orders
| 88.4
| 103.0
| 83.3
| 70.6
| 56.8
| +56%
|
Sales
| 73.3
| 74.0
| 55.7
| 77.3
| 58.0
| +26%
|
The Entertainment division delivered another quarter of good order intake which grew 56% year-over-year. All business units contributed to the year-over-year growth with Cinema showing particularly strong order intake growth across all regions.
Sales for the division grew year-over-year in both the Cinema and the Venues & Hospitalities segments.
Enterprise
(in millions of euro)
| 3Q21
| 2Q21
| 1Q21
| 4Q20
| 3Q20
| Change 3Q21 vs 3Q20
|
Orders
| 71.5
| 58.9
| 51.8
| 52.1
| 48.6
| +47%
|
Sales
| 52.0
| 51.3
| 52.5
| 53.9
| 50.0
| +4%
|
With a 47% increase in order intake versus last year, Enterprise generated orders close to pre-covid levels (3Q19) with both segments registering strong uptakes.
A strong double-digit year-over-year growth in sales for ClickShare was partly offset by deployment delays in Control rooms.
With respect to ClickShare, a significant increase in order intake (+75% vs last year), double digit growth in sales and strong sell-out from distribution channels reflect improving back-to-office dynamics in the EMEA and the Americas regions.
Control Rooms’ orders also rebounded from last year’s Q3 but sales were down due to large revenue project delays caused primarily by prolonged covid restrictions in the APAC region.
Healthcare
(in millions of euro)
| 3Q21
| 2Q21
| 1Q21
| 4Q20
| 3Q20
| Change 3Q21 vs 3Q20
|
Orders
| 65.2
| 74.7
| 93.9
| 67.0
| 52.3
| +25%
|
Sales
| 61.3
| 68.9
| 63.5
| 64.3
| 59.3
| +3%
|
With a decent order intake, Healthcare saw its orderbook further strengthen while sales were severely affected by component shortages both in the Diagnostics and the Surgical segment.
Quote of the CEO's, An Steegen & Charles Beauduin
“We are now seeing clear signs of recovery in Barco’s demand, in particular in Enterprise and Entertainment, fueled by the back-to-office and back-to-cinema trends. This rebound reflects the strength of Barco’s best-in-class product portfolio.
Nevertheless, we do expect supply chain challenges to persist and hamper the pace of converting our record level orderbook into sales as we enter 2022.”
Outlook 2021 - current
The following statements are forward looking, and actual results may differ materially.
We continue to see uncertainty related to supply chain constraints and expect now to deliver a mid-single-digit percentage sales growth this year versus last year with full year EBITDA margin higher than the first semester of 2021.
The information given in this press release has not been reviewed by the statutory auditor.